BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9811410)

  • 1. Role of selectin-dependent adhesion in cardiac allograft rejection.
    Yamazaki S; Isobe M; Suzuki J; Tojo S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1998 Oct; 17(10):1007-16. PubMed ID: 9811410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of donor- and recipient-derived selectins in cardiac allograft rejection.
    Izawa A; Ueno T; Jurewicz M; Ito T; Tanaka K; Takahashi M; Ikeda U; Sobolev O; Fiorina P; Smith RN; Hynes RO; Abdi R
    J Am Soc Nephrol; 2007 Nov; 18(11):2929-36. PubMed ID: 17928506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular cell adhesion molecule-1 and selectin ligands in acute cardiac allograft rejection: a study on gene-deficient mouse models.
    Lácha J; Bushell A; Smetana K; Rossmann P; Pribylová P; Wood K; Malý P
    J Leukoc Biol; 2002 Feb; 71(2):311-8. PubMed ID: 11818453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-selectin expression in human cardiac grafts with cellular rejection.
    Allen MD; McDonald TO; Himes VE; Fishbein DP; Aziz S; Reichenbach DD
    Circulation; 1993 Nov; 88(5 Pt 2):II243-7. PubMed ID: 7693367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy.
    Funeshima-Fuji N; Fujino M; Xie L; Kimura H; Takahara S; Ezaki T; Zhu BT; Li XK
    J Heart Lung Transplant; 2009 Feb; 28(2):176-82. PubMed ID: 19201344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of adhesion molecules on the endothelia of rejecting cardiac allografts.
    Lemström K; Koskinen P; Häyry P
    J Heart Lung Transplant; 1995; 14(2):205-13. PubMed ID: 7779837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival.
    Hölschermann H; Stadlbauer TH; Wagner AH; Fingerhuth H; Muth H; Rong S; Güler F; Tillmanns H; Hecker M
    Cardiovasc Res; 2006 Aug; 71(3):527-36. PubMed ID: 16822491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection.
    Wu GD; Bowdish ME; Jin YS; Zhu H; Mitsuhashi N; Barsky LW; Barr ML
    J Heart Lung Transplant; 2005 Dec; 24(12):2160-9. PubMed ID: 16364866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
    Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
    Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic rejection in experimental cardiac transplantation in a rat model.
    Karnovsky MJ; Russell ME; Hancock W; Sayegh MH; Adams DH
    Clin Transplant; 1994 Jun; 8(3 Pt 2):308-12. PubMed ID: 8061372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
    Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
    J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection.
    Mulligan MS; Warner RL; McDuffie JE; Bolling SF; Sarma JV; Ward PA
    Exp Mol Pathol; 2000 Aug; 69(1):1-9. PubMed ID: 10891287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.